Delivery Order SPE2DB20D1100-SPE2DB24FD7T0

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,369.11, is for the delivery of Lamictal 25 mg dispersible tablets. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQELK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,042.45 firm fixed-price delivery order is for the supply of 4,567,985,152 units of the prescription medication Lamictal 100 mg tablets. The contract has an ultimate completion date of April 22, 2025 and was awarded on April 21, 2025. This delivery order is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to deliver Lamictal ODT 200 mg tablets. The $5,460.39 firm fixed-price delivery order has a completion date of July 24, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, identified as SPE2DB22D1017|SPE2DB25FG0GR, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,070.74 firm-fixed-price delivery order is for the supply of 4,567,942,237 units of the medication Lamictal 150 mg tablet. The contract has an ultimate completion date of April 17, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $22,501.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4562468216 LAMICTAL 25 MG DISPER TABLET 100S, with a period of performance through October 16, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,145.23 firm fixed-price delivery order is for the supply of 4,566,601,316 units of LAMICTAL 25 MG DISPER TABLETS 100S, with a period of performance through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,982.15, is for the delivery of Lamictal 100 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Lamictal 25 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,797.52 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 21, 2024 and is a delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen maintains a $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,875.69 Firm Fixed Price Delivery Order supports the procurement of 4,563,373,292 units of Lamictal 100 mg tablets for the DLA. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999...
This contract award, SPE2DB20D3103|SPE2DB24FP2Q9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.24 firm fixed price delivery order is for the supply of LAMICTAL 200 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD7T0
    Delivery Order

This federal contract award, with ID SPE2DB20D1100|SPE2DB24FD7T0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamictal 5 mg dispersible tablets in 100-count packages. The $29,600.76 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for supplying a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on September 12, 2024.

Generated 12/11/24, 9:13 AM